How Chlorine Dioxide Damages Bacterial Cells: Thiol Oxidation and Oxidative Stress

    An evidence-led guide for understanding biofilm in managed water and hygiene systems.

    Evidence-led guidance
    Expert Reviewed

    Chlorine dioxide inactivates bacteria mainly by oxidising sulphur-containing and aromatic amino acids in proteins, with cellular thiols an early target. A 2026 Aeromonas study illustrates that mechanism and its dose-dependence, but it does not establish product efficacy or a commercial dose.

    A selective oxidant, not a chlorinating agent

    Chlorine dioxide is a dissolved free radical that reacts by taking single electrons from susceptible molecules. Unlike hypochlorous acid, it does not add chlorine atoms to organic material, which is why it does not form trihalomethanes. Its reactivity is selective: it attacks reduced sulphur groups (thiols such as cysteine and glutathione), the amino acids tyrosine and tryptophan, and some other electron-rich sites, while being comparatively unreactive towards many carbohydrates and saturated hydrocarbons.

    Because thiol groups sit in enzyme active sites, membrane transport proteins and the cell's own antioxidant buffer, oxidising them disrupts several functions at once: enzymes lose activity, membranes become leaky, protein synthesis falters and the cell's capacity to repair oxidative damage is consumed. Loss of membrane integrity and leakage of cell contents are commonly reported endpoints in chlorine dioxide inactivation studies.

    The 2026 Aeromonas study

    A study by Cao and colleagues, available online in Fish & Shellfish Immunology on 3 September 2026 (in press; doi 10.1016/j.fsi.2026.111707), examined chlorine dioxide against bacterial pathogens of farmed rainbow trout. Chlorine dioxide markedly inhibited Aeromonas hydrophila and Aeromonas salmonicida and reduced the thiol content of the bacterial cells in a concentration-dependent manner, which the authors interpret as evidence that thiol-associated oxidative damage contributes to its antibacterial action.

    The same study exposed live fish to chlorine dioxide. Low-to-moderate exposure activated antioxidant and innate immune responses, whereas higher concentrations caused mortality, liver and gill injury, depletion of glutathione (the cell's main thiol antioxidant), lipid peroxidation and immune disturbance. Transcriptome analysis of infected fish treated with chlorine dioxide showed changes in glutathione metabolism, xenobiotic metabolism and immune signalling pathways.

    Dose-response: the same chemistry cuts both ways

    The study's most useful lesson for water and hygiene practice is that the thiol chemistry that inactivates bacteria is not specific to bacteria. Host cells, including those of animals drinking or living in treated water, use the same glutathione system. Antibacterial benefit and host toxicity therefore sit on one dose-response curve, and the usable window between them depends on organism, exposure route, contact time and water chemistry. This is one reason biocidal product authorisations specify concentrations, exposure scenarios and species rather than leaving dosing open.

    Oxidant demand also matters. Chlorine dioxide is consumed by organic matter, biofilm and some materials before it reaches target cells, so the concentration applied and the concentration actually experienced by bacteria can differ substantially, as the dental waterline guide in this centre shows.

    What this study does and does not establish

    It establishes, in an aquaculture laboratory setting, that chlorine dioxide inhibits two Aeromonas species and depletes bacterial thiols in a concentration-dependent way, consistent with the oxidative mechanism described above, and that fish show a dose-dependent redox response with injury at higher exposures.

    It does not establish the efficacy of any ChloroKlean product, which was not tested. It does not provide a commercial dose for aquaculture, livestock, veterinary or water-system use; the concentrations were chosen for a mechanistic experiment and a toxicological boundary in one fish species. It is not a field trial, and the paper was in press at the time of writing, so figures may change in the final version. Any veterinary hygiene or drinking-water use must follow the product's authorised uses, label and a competent adviser or veterinarian, not this study.

    Evidence and uncertainty

    Published biofilm studies are valuable for understanding mechanisms, but their conditions may not match a particular installation. Species, surfaces, deposits and operating conditions should be recorded when interpreting evidence.

    For safety-critical systems, decisions should be documented through the relevant risk assessment and management plan.

    Choosing the next question

    A useful next step is to identify what is known, what is inferred and what needs verification. This avoids treating a general reference as a site diagnosis.

    Where a product is considered, confirm the intended use, authorisation and label directions independently of this educational guide.

    A proportionate biofilm-management approach

    Use this sequence to frame investigation and control; it is not a dosing protocol.

    1

    Define the system and risk

    Map wetted surfaces, operating conditions, users and relevant legal or sector guidance.

    2

    Gather evidence

    Review inspection, operational, residual and microbiological records rather than relying on one indicator.

    3

    Address contributing conditions

    Consider cleaning, hydraulics, nutrients, stagnation and equipment condition alongside any authorised biocide programme.

    4

    Verify and review

    Document the intervention and review results through the site’s written scheme or hygiene plan.

    Expert Insights

    "Biofilm control is a system-management question: chemistry, surfaces, flow, cleaning and verification all matter."

    ChloroKlean Technical Team

    Technical review team

    About the Reviewer

    Gavin Owen

    Managing Director, ChloroKlean

    Gavin Owen leads ChloroKlean's technical and commercial operations, bringing over 20 years of experience in industrial chemical distribution and water treatment. He oversees product development, regulatory compliance strategy, and the company's BPR compliance programme across PT2, PT4, PT5, and PT11 product types. Gavin works directly with water treatment professionals, facilities managers, and public health engineers across healthcare, leisure, food processing, and industrial sectors.

    BPR Compliance
    Water Treatment
    Legionella Control
    Industrial Disinfection

    Frequently Asked Questions

    Common questions about this topic, answered by our technical team.

    No. Both are oxidants, but hypochlorous acid chlorinates organic material whereas chlorine dioxide removes single electrons from selective targets such as thiols, tyrosine and tryptophan without adding chlorine. That difference underlies the different by-product profiles.

    No. The researchers used their own chlorine dioxide preparation in a laboratory and aquaculture setting. No ChloroKlean product was tested, and the study contains no dosing guidance for any commercial product.

    Because animal cells rely on the same thiol-based glutathione system that chlorine dioxide oxidises in bacteria. Selectivity comes from dose, exposure route and contact time, not from a chemistry that only affects bacteria.

    Start with the system’s risk assessment, operational records and applicable sector guidance. Use the referenced sources to frame questions, not to replace competent site assessment.

    Scope and safe-use note

    • This is general educational information, not a dosing instruction or a product label.
    • Use only a biocidal product authorised for its intended product type and follow its label, Safety Data Sheet and site risk assessment.
    • Investigate system design, cleaning, monitoring and microbiological findings with a competent person where there is a health risk.

    Published evidence about a disinfectant or another product does not establish efficacy, authorisation or an appropriate use pattern for any ChloroKlean product.

    Related Resources

    Continue exploring our knowledge base and product information.

    Sources & References

    This article references guidance from the following authoritative sources:

    External links open in a new window. ChloroKlean is not responsible for the content of external websites.

    Need Help Choosing the Right Product?

    Our technical team can advise on product selection, dosing, and compliance for your specific application.